Role of brain neuroactive steroids in the functional interplay between the GABAA and the NPY-Y1 receptor mediated signals in the amygdala

Pharmacology Biochemistry and Behavior

Volumn 84, Issue 4, 2006, Pages 568-580

  Eva, Carola ^a   Oberto, Alessandra ^a   Mele, Paolo ^a   Serra, Mariangela ^b   Biggio, Giovanni ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Amygdala; Ethanol; GABA; Neuroactive steroids; Neuropeptide Y; Pregnancy; Stress; Transgenic mice; Y1 receptors

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; ABECARNIL; ALCOHOL; DIAZEPAM; NEUROPEPTIDE Y; STEROID; TETRAHYDRODEOXYCORTICOSTERONE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y Y1 RECEPTOR; NEUROPEPTIDE Y-Y1 RECEPTOR;

ALCOHOL CONSUMPTION; AMYGDALOID NUCLEUS; ARTICLE; BEHAVIOR; BRAIN REGION; CONCENTRATION (PARAMETERS); FEEDING; GABAERGIC SYSTEM; GENE EXPRESSION; HORMONE ACTION; HUMAN; MORPHOLOGY; NERVE CELL EXCITABILITY; NEUROTRANSMISSION; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; REPORTER GENE; SEDATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; ANIMAL; BRAIN LEVEL; GENE EXPRESSION REGULATION; GENETICS; REVIEW; SYNAPTIC TRANSMISSION;

MURINAE; MUS; MUS MUSCULUS;

AMYGDALA; ANIMALS; BRAIN CHEMISTRY; GENE EXPRESSION REGULATION; HUMANS; NEUROPEPTIDE Y; RECEPTORS, GABA-A; RECEPTORS, NEUROPEPTIDE Y; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 34447122228     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.05.014     Document Type: Article

References (175)

1. Akwa Y., Purdy R.H., Koob G.F., and Britton K.T. The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav Brain Res 106 (1999) 119-125
2. Allen Y.S., Adrian T.E., Allen J.M., Tatemoto K., Crow T.J., Bloom S.R., et al. Neuropeptide Y distribution in the rat brain. Science 221 (1983) 877-879
3. Azzolina B., Ellsworth K., Andersson S., Geissler W., Bull H.G., and Harris G.S. Inhibition of rat alphareductases by finasteride: evidence for isozyme differences in the mechanism of inhibition. J Steroid Biochem Mol Biol 61 (1997) 55-64
4. Bacci A., Huguenard J.R., and Prince D.A. Differential modulation of synaptic transmission by neuropeptide Y in rat neocortical neurons. Proc Natl Acad Sci U S A 99 (2002) 17125-17130
5. Bannon A.W., Seda J., Carmouche M., Francis J.M., Norman M.H., Karbon B., et al. Behavioral characterization of neuropeptide Y knockout mice. Brain Res 868 (2000) 79-87
6. Baraban S.C., Hollopeter G., Erickson J.C., Schwartzkroin P.A., and Palmiter R.D. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J Neurosci 17 (1997) 8927-8936
7. Barbaccia M.L., Roscetti G., Bolacchi F., Concas A., Mostallino M.C., Purdy R.H., et al. Stress-induced increase in brain neuroactive steroids: antagonism by abecarnil. Pharmacol Biochem Behav 54 (1996) 205-210
8. Barbaccia M.L., Roscetti G., Trabucchi M., Purdy R.H., Mostallino M.C., Concas A., et al. The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br J Pharmacol 120 (1997) 1582-1588
9. Barbaccia M.L., Affricano D., Trabucchi M., Purdy R.H., Colombo G., Agabio R., et al. Ethanol markedly increases "GABAergic" neurosteroids in alcohol-preferring rats. Eur J Pharmacol 384 (1999) R1-R2
10. Barbaccia M.L., Serra M., Purdy R.H., and Biggio G. Stress and neuroactive steroids. Int Rev Neurobiol 46 (2001) 243-272
11. Becker H.C., and Jarvis M.F. Chronic ethanol exposure selectively increases diazepam-insensitive [3H]RO15-4513 binding in mouse cerebellum. Eur J Pharmacol 296 (1996) 43-46
12. Belelli D., and Lambert J.J. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci 6 (2005) 565-575
13. Benmaamar R., Pham-Le B.T., Marescaux C., Pedrazzini T., and Depaulis A. Induced down-regulation of neuropeptide Y-Y1 receptors delays initiation of kindling. Eur J Neurosci 18 (2003) 768-774
14. Besecke L.M., Wolfe A.M., Pierce M.E., Takahashi J.S., and Levine J.E. Neuropeptide Y stimulates luteinizing hormone-releasing hormone release from superfused hypothalamic GT1-7 cells. Endocrinology 135 (1994) 1621-1627
15. Bicikova M., Dibbelt L., Hill M., Hampl R., and Starka L. Allopregnanolone in women with premenstrual syndrome. Horm Metab Res 30 (1998) 227-230
16. Biggio G., and Purdy R.H. Neurosteroids and brain function. In: Bradley R.J., Harris R.A., and Jenner P. (Eds). International review of neurobiology Academic (2001)
17. Biggio G., Follesa P., Sanna E., Purdy R.H., and Concas A. GABAA-receptor plasticity during long-term exposure to and withdrawal from progesterone. Int Rev Neurobiol 46 (2001) 207-241
18. Biggio G., Dazzi L., Biggio F., Mancuso L., Talani G., Busonero F., et al. Molecular mechanisms of tolerance to and withdrawal of GABA(A) receptor modulators. Eur Neuropsychopharmacol 13 (2003) 411-423
19. Bison S., and Crews F. Alcohol withdrawal increases neuropeptide Y immunoreactivity in rat brain. Alcohol Clin Exp Res 27 (2003) 1173-1183
20. Blomqvist A.G., and Herzog H. Y-receptor subtypes - how many more?. Trends Neurosci 20 (1997) 294-298
21. Bolwig T.G., Woldbye D.P., and Mikkelsen J.D. Electroconvulsive therapy as an anticonvulsant: a possible role of neuropeptide Y (NPY). J ECT 15 (1999) 93-101
22. Broberger C., de L.L., Sutcliffe J.G., and Hokfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 402 (1998) 460-474
23. Broberger C., Johansen J., Johansson C., Schalling M., and Hokfelt T. The neuropeptide Y/agouti generelated protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci U S A 95 (1998) 15043-15048
24. Broqua P., Wettstein J.G., Rocher M.N., Gauthier-Martin B., and Junien J.L. Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behav Pharmacol 6 (1995) 215-222
25. Brot M.D., Koob G.F., and Britton K.T. Anxiolytic effects of steroid hormones during the estrous cycle. Interactions with ethanol. Recent Dev Alcohol 12 (1995) 243-259
26. Caberlotto L., Fuxe K., and Hurd Y.L. Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum. J Chem Neuroanat 20 (2000) 327-337
27. Catzeflis C., Pierroz D.D., Rohner-Jeanrenaud F., Rivier J.E., Sizonenko P.C., and Aubert M.L. Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats. Endocrinology 132 (1993) 224-234
28. Chen S., Huang X., Zeng X.J., Sieghart W., and Tietz E.I. Benzodiazepine-mediated regulation of alpha1, alpha2, beta1-3 and gamma2 GABA(A) receptor subunit proteins in the rat brain hippocampus and cortex. Neuroscience 93 (1999) 33-44
29. Chronwall B.M., and Zukowska Z. Neuropeptide Y, ubiquitous and elusive. Peptides 25 (2004) 359-363
30. Chronwall B.M., DiMaggio D.A., Massari V.J., Pickel V.M., Ruggiero D.A., and O'Donohue T.L. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 15 (1985) 1159-1181
31. Clark J.T., Keaton A.K., Sahu A., Kalra S.P., Mahajan S.C., and Gudger J.N. Neuropeptide Y (NPY) levels in alcoholic and food restricted male rats: implications for site selective function. Regul Pept 75-76 (1998) 335-345
32. Colmers W.F., and Bleakman D. Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci 17 (1994) 373-379
33. Concas A., Mostallino M.C., Porcu P., Follesa P., Barbaccia M.L., Trabucchi M., et al. Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc Natl Acad Sci U S A 95 (1998) 13284-13289
34. Corda M.G., and Biggio G. Stress and GABAergic transmission: biochemical and behavioural studies. Adv Biochem Psychopharmacol 41 (1986) 121-136
35. Corda M.G., Giorgi O., Gatta F., and Biggio G. Long-lasting proconflict effect induced by chronic administration of the beta-carboline derivative FG 7142. Neurosci Lett 62 (1985) 237-240
36. Costa E., and Guidotti A. Benzodiazepines on trial: a research strategy for their rehabilitation. Trends Pharmacol Sci 17 (1996) 192-200
37. Costa E., Guidotti A., and Mao C.C. Evidence for involvement of GABA in the action of benzodiazepines: studies on rat cerebellum. Adv Biochem Psychopharmacol (1975) 113-130
38. Cowley M.A., Smart J.L., Rubinstein M., Cerdan M.G., Diano S., Horvath T.L., et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411 (2001) 480-484
39. cuna-Goycolea C., Tamamaki N., Yanagawa Y., Obata K., and van den Pol A.N. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus. J Neurosci 25 (2005) 7406-7419
40. de Lanerolle N.C., Kim J.H., Robbins R.J., and Spencer D.D. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res 495 (1989) 387-395
41. de Quidt M.E., and Emson P.C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system-II. Immunohistochemical analysis. Neuroscience 18 (1986) 545-618
42. Devaud L.L., Purdy R.H., Finn D.A., and Morrow A.L. Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal. J Pharmacol Exp Ther 278 (1996) 510-517
43. Devaud L.L., Fritschy J.M., Sieghart W., and Morrow A.L. Bidirectional alterations of GABA(A) receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal. J Neurochem 69 (1997) 126-130
44. Dorow R., Horowski R., Paschelke G., and Amin M. Severe anxiety induced by FG 7142, a betacarboline ligand for benzodiazepine receptors. Lancet 2 (1983) 98-99
45. Dumont Y., Martel J.C., Fournier A., St-Pierre S., and Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol 38 (1992) 125-167
46. Dumont Y., Jacques D., Bouchard P., and Quirion R. Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains. J Comp Neurol 402 (1998) 372-384
47. Ehlers C.L., Somes C., Seifritz E., and Rivier J.E. CRF/NPY interactions: a potential role in sleep dysregulation in depression and anxiety. Depress Anxiety 6 (1997) 1-9
48. Ehlers C.L., Li T.K., Lumeng L., Hwang B.H., Somes C., Jimenez P., et al. Neuropeptide Y levels in ethanol-naive alcohol-preferring and nonpreferring rats and in Wistar rats after ethanol exposure. Alcohol Clin Exp Res 22 (1998) 1778-1782
49. Engel S.R., and Grant K.A. Neurosteroids and behavior. Int Rev Neurobiol 46 (2001) 321-348
50. Erickson J.C., Clegg K.E., and Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381 (1996) 415-421
51. Eva C., Keinanen K., Monyer H., Seeburg P., and Sprengel R. Molecular cloning of a novel G proteincoupled receptor that may belong to the neuropeptide receptor family. FEBS Lett 271 (1990) 81-84
52. Eva C., Oberto A., Sprengel R., and Genazzani E. The murine NPY-1 receptor gene. Structure and delineation of tissue-specific expression. FEBS Lett 314 (1992) 285-288
53. Eva C, Serra M, Mele P, Panzica GC, Oberto A. Physiology and gene regulation of brain NPY Y1 receptor. Front Neuroendocrinol, submitted for publication.
54. Ferrara G., Serra M., Zammaretti F., Pisu M.G., Panzica G.C., Biggio G., et al. Increased expression of the neuropeptide Y receptor Y(1) gene in the medial amygdala of transgenic mice induced by longterm treatment with progesterone or allopregnanolone. J Neurochem 79 (2001) 417-425
55. Finn D.A., Ford M.M., Wiren K.M., Roselli C.E., and Crabbe J.C. The role of pregnane neurosteroids in ethanol withdrawal: behavioral genetic approaches. Pharmacol Ther 101 (2004) 91-112
56. Follesa P., Floris S., Tuligi G., Mostallino M.C., Concas A., and Biggio G. Molecular and functional adaptation of the GABA(A) receptor complex during pregnancy and after delivery in the rat brain. Eur J Neurosci 10 (1998) 2905-2912
57. Follesa P., Serra M., Cagetti E., Pisu M.G., Porta S., Floris S., et al. Allopregnanolone synthesis in cerebellar granule cells: roles in regulation of GABA(A) receptor expression and function during progesterone treatment and withdrawal. Mol Pharmacol 57 (2000) 1262-1270
58. Follesa P., Cagetti E., Mancuso L., Biggio F., Manca A., Maciocco E., et al. Increase in expression of the GABA(A) receptor alpha(4) subunit gene induced by withdrawal of, but not by long-term treatment with, benzodiazepine full or partial agonists. Brain Res Mol Brain Res 92 (2001) 138-148
59. Follesa P., Porcu P., Sogliano C., Cinus M., Biggio F., Mancuso L., et al. Changes in GABAA receptor gamma 2 subunit gene expression induced by long-term administration of oral contraceptives in rats. Neuropharmacology 42 (2002) 325-336
60. Follesa P., Biggio F., Talani G., Murru L., Serra M., Sanna E., et al. Neurosteroids, GABA(A) receptors, and ethanol dependence. Psychopharmacology (Berl) (2005) 1-14
61. Gariboldi M., Conti M., Cavaleri D., Samanin R., and Vezzani A. Anticonvulsant properties of BIBP3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors. Eur J Neurosci 10 (1998) 757-759
62. Genazzani A.R., Petraglia F., Bernardi F., Casarosa E., Salvestroni C., Tonetti A., et al. Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab 83 (1998) 2099-2103
63. Gerald C., Walker M.W., Criscione L., Gustafson E.L., Batzl-Hartmann C., Smith K.E., et al. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382 (1996) 168-171
64. Glass M.J., Billington C.J., and Levine A.S. Opioids and food intake: distributed functional neural pathways?. Neuropeptides 33 (1999) 360-368
65. Gorin R.E., Crabbe J.C., Tanchuck M.A., Long S.L., and Finn D.A. Effects of finasteride on chronic and acute ethanol withdrawal severity in the WSP and WSR selected lines. Alcohol Clin Exp Res 29 (2005) 939-948
66. Grobin A.C., Matthews D.B., Devaud L.L., and Morrow A.L. The role of GABA(A) receptors in the acute and chronic effects of ethanol. Psychopharmacology (Berl) 139 (1998) 2-19
67. Guidotti A., and Costa E. Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5 alpha-tetrahydroprogesterone (allopregnanolone) availability?. Biol Psychiatry 44 (1998) 865-873
68. Gustafson E.L., Card J.P., and Moore R.Y. Neuropeptide Y localization in the rat amygdaloid complex. J Comp Neurol 251 (1986) 349-362
69. Haefely W. Biological basis of drug-induced tolerance, rebound, and dependence. Contribution of recent research on benzodiazepines. Pharmacopsychiatry 19 (1986) 353-361
70. Hahn T.M., Breininger J.F., Baskin D.G., and Schwartz M.W. Coexpression of Agrp and NPY in fastingactivated hypothalamic neurons. Nat Neurosci 1 (1998) 271-272
71. Heilig M. Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul Pept 59 (1995) 201-205
72. Heilig M., and Murison R. Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat. Regul Pept 19 (1987) 221-231
73. Heilig M., Soderpalm B., Engel J.A., and Widerlov E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology (Berl) 98 (1989) 524-529
74. Heilig M., McLeod S., Koob G.K., and Britton K.T. Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test. Regul Pept 41 (1992) 61-69
75. Heilig M., Koob G.F., Ekman R., and Britton K.T. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci 17 (1994) 80-85
76. Herzog H., Hort Y.J., Ball H.J., Hayes G., Shine J., and Selbie L.A. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci U S A 89 (1992) 5794-5798
77. Hokfelt T., Broberger C., Zhang X., Diez M., Kopp J., Xu Z., et al. Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system. Brain Res Brain Res Rev 26 (1998) 154-166
78. Horvath T.L., Bechmann I., Naftolin F., Kalra S.P., and Leranth C. Heterogeneity in the neuropeptide Ycontaining neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations. Brain Res 756 (1997) 283-286
79. Horvath T.L., Pu S., Dube M.G., Diano S., and Kalra S.P. A GABA-neuropeptide Y (NPY) interplay in LH release. Peptides 22 (2001) 473-481
80. Howell O.W., Scharfman H.E., Herzog H., Sundstrom L.E., Beck-Sickinger A., and Gray W.P. Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells. J Neurochem 86 (2003) 646-659
81. Jinno S., and Kosaka T. Patterns of expression of neuropeptides in GABAergic nonprincipal neurons in the mouse hippocampus: quantitative analysis with optical disector. J Comp Neurol 461 (2003) 333-349
82. Kalra S.P., and Crowley WR. Neuropeptide Y: a novel neuroendocrine peptide in the control of pituitary hormone secretion, and its relation to luteinizing hormone. Front Neuroendocrinol 13 (1992) 1-46
83. Kalra S.P., Dube M.G., Sahu A., Phelps C.P., and Kalra P.S. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci U S A 88 (1991) 10931-10935
84. Kalra S.P., Fuentes M., Fournier A., Parker S.L., and Crowley W.R. Involvement of the Y-1 receptor subtype in the regulation of luteinizing hormone secretion by neuropeptide Y in rats. Endocrinology 130 (1992) 3323-3330
85. Kanatani A., Mashiko S., Murai N., Sugimoto N., Ito J., Fukuroda T., et al. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptordeficient mice. Endocrinology 141 (2000) 1011-1016
86. Kask A., Rago L., and Harro J. Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam. Eur J Pharmacol 317 (1996) R3-R4
87. Kask A., Rago L., and Harro J. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226. Br J Pharmacol 124 (1998) 1507-1515
88. Kask A., Nguyen H.P., Pabst R., and von H.S. Neuropeptide Y Y1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone-induced anxiety. Neuroscience 104 (2001) 799-806
89. Khisti R.T., Penland S.N., VanDoren M.J., Grobin A.C., and Morrow A.L. GABAergic neurosteroid modulation of ethanol actions. World J Biol Psychiatry 3 (2002) 87-95
90. Kinoshita H., Jessop D.S., Finn D.P., Coventry T.L., Roberts D.J., Ameno K., et al. Acute ethanol decreases NPY mRNA but not POMC mRNA in the arcuate nucleus. Neuroreport 11 (2000) 3517-3519
91. Kishi T., Aschkenasi C.J., Choi B.J., Lopez M.E., Lee C.E., Liu H., et al. Neuropeptide Y Y1 receptor mRNA in rodent brain: distribution and colocalization with melanocortin-4 receptor. J Comp Neurol 482 (2005) 217-243
92. Koob G.F. Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 27 (2003) 232-243
93. Koob G.F., Roberts A.J., Schulteis G., Parsons L.H., Heyser C.J., Hyytia P., et al. Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin Exp Res 22 (1998) 3-9
94. Krause J., Eva C., Seeburg P.H., and Sprengel R. Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. Mol Pharmacol 41 (1992) 817-821
95. Krysiak R., Obuchowicz E., and Herman Z.S. Diazepam and buspirone alter neuropeptide Y-like immunoreactivity in rat brain. Neuropeptides 33 (1999) 542-549
96. Krysiak R., Obuchowicz E., and Herman Z.S. Conditioned fear-induced changes in neuropeptide Y-like immunoreactivity in rats: the effect of diazepam and buspirone. Neuropeptides 34 (2000) 148-157
97. Kushi A., Sasai H., Koizumi H., Takeda N., Yokoyama M., and Nakamura M. Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Proc Natl Acad Sci U S A 95 (1998) 15659-15664
98. Lambert J.J., Belelli D., Harney S.C., Peters J.A., and Frenguelli B.G. Modulation of native and recombinant GABA(A) receptors by endogenous and synthetic neuroactive steroids. Brain Res Brain Res Rev 37 (2001) 68-80
99. Larhammar D., and Salaneck E. Molecular evolution of NPY receptor subtypes. Neuropeptides 38 (2004) 141-151
100. Lundell I., Blomqvist A.G., Berglund M.M., Schober D.A., Johnson D., Statnick M.A., et al. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J Biol Chem 270 (1995) 29123-29128
101. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (1986) 1004-1007
102. Mannon P.J., and Mele J.M. Peptide YY Y1 receptor activates mitogen-activated protein kinase and proliferation in gut epithelial cells via the epidermal growth factor receptor. Biochem J 350 Pt 3 (2000) 655-661
103. McDonald A.J., and Pearson J.C. Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala. Neurosci Lett 100 (1989) 53-58
104. Mele P., Oberto A., Serra M., Pisu M.G., Floris I., Biggio G., et al. Increased expression of the gene for the Y1 receptor of neuropeptide Y in the amygdala and paraventricular nucleus of Y1R/LacZ transgenic mice in response to restraint stress. J Neurochem 89 (2004) 1471-1478
105. Mele P, Serra M, Collura D, Pisu MG, Biggio G and Eva C. Fluctuation in brain concentration of neuroactive steroids modulates NPY Y1 receptor signalling in the amygdala of transgenic mice during ethanol withdrawal. Submitted for publication.
106. Mhatre M.C., and Ticku M.K. Chronic ethanol administration alters gamma-aminobutyric acidA receptor gene expression. Mol Pharmacol 42 (1992) 415-422
107. Mhatre M., Mehta A.K., and Ticku M.K. Chronic ethanol administration increases the binding of the benzodiazepine inverse agonist and alcohol antagonist [3H]RO15-4513 in rat brain. Eur J Pharmacol 153 (1988) 141-145
108. Mhatre M.C., Pena G., Sieghart W., and Ticku M.K. Antibodies specific for GABAA receptor alpha subunits reveal that chronic alcohol treatment down-regulates alpha-subunit expression in rat brain regions. J Neurochem 61 (1993) 1620-1625
109. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., et al. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50 (1998) 143-150
110. Mikkelsen J.D., Woldbye D., Kragh J., Larsen P.J., and Bolwig T.G. Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and the dentate gyrus. Brain Res Mol Brain Res 23 (1994) 317-322
111. Mikkelsen J.D., Karle J., and Madsen T.M. Intrahippocampal infusion of antisense oligodeoxynucleotide to the GABA(A) receptor gamma2 subunit enhances neuropeptide Y gene expression. Brain Res Bull 54 (2001) 91-99
112. Moran M.H., and Smith S.S. Progesterone withdrawal I: pro-convulsant effects. Brain Res 807 (1998) 84-90
113. Morrow A.L., Montpied P., Lingford-Hughes A., and Paul S.M. Chronic ethanol and pentobarbital administration in the rat: effects on GABAA receptor function and expression in brain. Alcohol 7 (1990) 237-244
114. Morrow A.L., Janis G.C., VanDoren M.J., Matthews D.B., Samson H.H., Janak P.H., et al. Neurosteroids mediate pharmacological effects of ethanol: a new mechanism of ethanol action?. Alcohol Clin Exp Res 23 (1999) 1933-1940
115. Morrow A.L., VanDoren M.J., Penland S.N., and Matthews D.B. The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence. Brain Res Brain Res Rev 37 (2001) 98-109
116. Mullins D., Kirby D., Hwa J., Guzzi M., Rivier J., and Parker E. Identification of potent and selective neuropeptide Y Y(1) receptor agonists with orexigenic activity in vivo. Mol Pharmacol 60 (2001) 534-540
117. Naveilhan P., Canals J.M., Valjakka A., Vartiainen J., Arenas E., and Ernfors P. Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism. Eur J Neurosci 13 (2001) 2241-2246
118. Naveilhan P., Hassani H., Lucas G., Blakeman K.H., Hao J.X., Xu X.J., et al. Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor. Nature 409 (2001) 513-517
119. Nie M., and Selbie L.A. Neuropeptide Y Y1 and Y2 receptor-mediated stimulation of mitogen-activated protein kinase activity. Regul Pept 75-76 (1998) 207-213
120. Oberto A., Tolosano E., Brusa R., Altruda F., Panzica G., and Eva C. The murine Y1 receptor 5′ upstream sequence directs cell-specific and developmentally regulated LacZ expression in transgenic mice CNS. Eur J Neurosci 10 (1998) 3257-3268
121. Oberto A., Panzica G., Altruda F., and Eva C. Chronic modulation of the GABA(A) receptor complex regulates Y1 receptor gene expression in the medial amygdala of transgenic mice. Neuropharmacology 39 (2000) 227-234
122. Oberto A., Panzica G.C., Altruda F., and Eva C. GABAergic and NPY-Y(1) network in the medial amygdala: a neuroanatomical basis for their functional interaction. Neuropharmacology 41 (2001) 639-642
123. Oberto A., Serra M., Pisu M.G., Biggio G., and Eva C. Changes in expression of the neuropeptide Y Y1 receptor gene in the medial amygdala of transgenic mice during pregnancy and after delivery. J Neurochem 82 (2002) 1272-1281
124. Olsen R.W., Liang J., Cagetti E., and Spigelman I. Plasticity of GABAA receptors in brains of rats treated with chronic intermittent ethanol. Neurochem Res 30 (2005) 1579-1588
125. Ovesjo M.L., Gamstedt M., Collin M., and Meister B. GABAergic nature of hypothalamic leptin target neurones in the ventromedial arcuate nucleus. J Neuroendocrinol 13 (2001) 505-516
126. Pandey S.C. Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene. [Review] [70 refs]. Trends Pharmacol Sci 24 (2003) 456-460
127. Pedrazzini T., Seydoux J., Kunstner P., Aubert J.F., Grouzmann E., Beermann F., et al. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat Med 4 (1998) 722-726
128. Pickel V.M., Beck-Sickinger A.G., Chan J., and Weiland H.A. Y1 receptors in the nucleus accumbens: ultrastructural localization and association with neuropeptide Y. J Neurosci Res 52 (1998) 54-68
129. Pronchuk N., Beck-Sickinger A.G., and Colmers W.F. Multiple NPY receptors Inhibit GABA(A) synaptic responses of rat medial parvocellular effector neurons in the hypothalamic paraventricular nucleus. Endocrinology 143 (2002) 535-543
130. Pu S., Jain M.R., Horvath T.L., Diano S., Kalra P.S., and Kalra S.P. Interactions between neuropeptide Y and gamma-aminobutyric acid in stimulation of feeding: a morphological and pharmacological analysis. Endocrinology 140 (1999) 933-940
131. Purdy R.H., Morrow A.L., Moore Jr. P.H., and Paul S.M. Stress-induced elevations of gammaaminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci U S A 88 (1991) 4553-4557
132. Raposinho P.D., Pierroz D.D., Broqua P., White R.B., Pedrazzini T., and Aubert M.L. Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism. Mol Cell Endocrinol 185 (2001) 195-204
133. Reddy D.S., and Rogawski M.A. Stress-induced deoxycorticosterone-derived neurosteroids modulate GABA(A) receptor function and seizure susceptibility. J Neurosci 22 (2002) 3795-3805
134. Rose P.M., Fernandes P., Lynch J.S., Frazier S.T., Fisher S.M., Kodukula K., et al. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem 270 (1995) 29038
135. Roy A., and Pandey S.C. The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. Alcohol Clin Exp Res 26 (2002) 796-803
136. Rupprecht R., di M.F., Hermann B., Strohle A., Lancel M., Romeo E., et al. Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res Brain Res Rev 37 (2001) 59-67
137. Russ J.C. The image processing handbook (1995), CRC Press
138. Sajdyk T.J., Vandergriff M.G., and Gehlert D.R. Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur J Pharmacol 368 (1999) 143-147
139. Sajdyk T.J., Shekhar A., and Gehlert D.R. Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides 38 (2004) 225-234
140. Sanna E., Serra M., Cossu A., Colombo G., Follesa P., Cuccheddu T., et al. Chronic ethanol intoxication induces differential effects on GABAA and NMDA receptor function in the rat brain. Alcohol Clin Exp Res 17 (1993) 115-123
141. Sanna E., Mostallino M.C., Busonero F., Talani G., Tranquilli S., Mameli M., et al. Changes in GABA(A) receptor gene expression associated with selective alterations in receptor function and pharmacology after ethanol withdrawal. J Neurosci 23 (2003) 11711-11724
142. Sanna E., Talani G., Busonero F., Pisu M.G., Purdy R.H., Serra M., et al. Brain steroidogenesis mediates ethanol modulation of GABAA receptor activity in rat hippocampus. J Neurosci 24 (2004) 6521-6530
143. Sato I., Arima H., Ozaki N., Watanabe M., Goto M., Hayashi M., et al. Insulin inhibits neuropeptide Y gene expression in the arcuate nucleus through GABAergic systems. J Neurosci 25 (2005) 8657-8664
144. Schroeder J.P., Olive F., Koenig H., and Hodge C.W. Intra-amygdala infusion of the NPY Y1 receptor antagonist BIBP 3226 attenuates operant ethanol self-administration. Alcohol Clin Exp Res 27 (2003) 1884-1891
145. Serra M., Pisu M.G., Floris I., Cara V., Purdy R.H., and Biggio G. Social isolation-induced increase in the sensitivity of rats to the steroidogenic effect of ethanol. J Neurochem 85 (2003) 257-263
146. Serra M., Mostallino M.C., Talani G., Pisu M.G., Carta M., Mura M.L., et al. Social isolation-induced increase in α4 and δ subunits gene expression is associated with a greater efficacy of ethanol on steroidogenesis and GABAA receptor function. J Neurochem 98 (2006) 122-133
147. Sloviter RS. Calcium-binding protein (calbindin-D28k) and parvalbumin immunocytochemistry: localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity. J Comp Neurol 280 (1989) 183-196
148. Sloviter R.S. Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat: the "dormant basket cell" hypothesis and its possible relevance to temporal lobe epilepsy. Hippocampus 1 (1991) 41-66
149. Smith S.S., and Gong Q.H. Ethanol administration rapidly reverses alpha4 GABAA receptor subunit upregulation following steroid exposure. Neuropharmacology 47 (2004) 9-16
150. Sparta D.R., Fee J.R., Hayes D.M., Knapp D.J., MacNeil D.J., and Thiele T.E. Peripheral and central administration of a selective neuropeptide Y Y1 receptor antagonist suppresses ethanol intake by C57BL/6J mice. Alcohol Clin Exp Res 28 (2004) 1324-1330
151. St-Pierre J.A., Dumont Y., Nouel D., Herzog H., Hamel E., and Quirion R. Preferential expression of the neuropeptide Y Y1 over the Y2 receptor subtype in cultured hippocampal neurons and cloning of the rat Y2 receptor. Br J Pharmacol 123 (1998) 183-194
152. St-Pierre J.A., Nouel D., Dumont Y., Beaudet A., and Quirion R. Association of neuropeptide Y Y1 receptors with glutamate-positive and NPY-positive neurons in rat hippocampal cultures. Eur J Neurosci 12 (2000) 1319-1330
153. Starback P., Wraith A., Eriksson H., and Larhammar D. Neuropeptide Y receptor gene y6: multiple deaths or resurrections?. Biochem Biophys Res Commun 277 (2000) 264-269
154. Sullivan S.D., and Moenter S.M. Gamma-aminobutyric acid neurons integrate and rapidly transmit permissive and inhibitory metabolic cues to gonadotropin-releasing hormone neurons. Endocrinology 145 (2004) 1194-1202
155. Tatemoto K., Carlquist M., and Mutt V. Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296 (1982) 659-660
156. Thiele T.E., and Badia-Elder N.E. A role for neuropeptide Y in alcohol intake control: evidence from human and animal research. Physiol Behav 79 (2003) 95-101
157. Thiele T.E., Marsh D.J., Ste M.L., Bernstein I.L., and Palmiter R.D. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 396 (1998) 366-369
158. Thiele T.E., Koh M.T., and Pedrazzini T. Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J Neurosci 22 (2002) RC208
159. Thiele T.E., Sparta D.R., Hayes D.M., and Fee J.R. A role for neuropeptide Y in neurobiological responses to ethanol and drugs of abuse. Neuropeptides 38 (2004) 235-243
160. Thorsell A., Svensson P., Wiklund L., Sommer W., Ekman R., and Heilig M. Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress. Regul Pept 75-76 (1998) 247-254
161. Thorsell A., Carlsson K., Ekman R., and Heilig M. Behavioral and endocrine adaptation, and upregulation of NPY expression in rat amygdala following repeated restraint stress. Neuroreport 10 (1999) 3003-3007
162. Thorsell A., Michalkiewicz M., Dumont Y., Quirion R., Caberlotto L., Rimondini R., et al. Behavioral insensitivity to restraint stress,
163. VanDoren M.J., Matthews D.B., Janis G.C., Grobin A.C., Devaud L.L., and Morrow A.L. Neuroactive steroid 3alpha-hydroxy-5alpha-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol. J Neurosci 20 (2000) 1982-1989
164. Vezzani A., Sperk G., and Colmers W.F. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci 22 (1999) 25-30
165. Vezzani A., Moneta D., Mule F., Ravizza T., Gobbi M., and French-Mullen J. Plastic changes in neuropeptide Y receptor subtypes in experimental models of limbic seizures. Epilepsia 41 Suppl 6 (2000) S115-S121
166. Vezzani A., Michalkiewicz M., Michalkiewicz T., Moneta D., Ravizza T., Richichi C., et al. Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience 110 (2002) 237-243
167. Wahlestedt C., and Reis D.J. Neuropeptide Y-related peptides and their receptors-are the receptors potential therapeutic drug targets?. Annu Rev Pharmacol Toxicol 33 (1993) 309-352
168. Wang M., Backstrom T., Sundstrom I., Wahlstrom G., Olsson T., Zhu D., et al. Neuroactive steroids and central nervous system disorders. Int Rev Neurobiol 46 (2001) 421-459
169. Weinberg D.H., Sirinathsinghji D.J., Tan C.P., Shiao L.L., Morin N., Rigby M.R., et al. Cloning and expression of a novel neuropeptide Y receptor. J Biol Chem 271 (1996) 16435-16438
170. Wisialowski T., Parker R., Preston E., Sainsbury A., Kraegen E., Herzog H., et al. Adrenalectomy reduces neuropeptide Y-induced insulin release and NPY receptor expression in the rat ventromedial hypothalamus. J Clin Invest 105 (2000) 1253-1259
171. Woldbye D.P., Larsen P.J., Mikkelsen J.D., Klemp K., Madsen T.M., and Bolwig T.G. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nat Med 3 (1997) 761-764
172. Woods J.H., Katz J.L., and Winger G. Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 44 (1992) 151-347
173. amada K., Shibasaki T., Tsumori C., Imaki T., Hotta M., Wakabayashi I., et al. Neuropeptide Y reverses corticotropin-releasing hormone- and psychological stress-caused shortening of sodium pentobarbital-induced sleep in rats. Brain Res 725 (1996) 272-275
174. Zhang H., and Pandey S.C. Effects of PKA modulation on the expression of neuropeptide Y in rat amygdaloid structures during ethanol withdrawal. Peptides 24 (2003) 1397-1402
175. Zhang L.P., and Wang L. Changes of brain neuropeptide Y and its receptors in rats with flurazepam tolerance and dependence. Acta Pharmacol Sin 26 (2005) 1290-1296